GSK Aktie
| 22,19EUR | -0,01EUR | -0,05% |
WKN DE: A3DMB5 / ISIN: GB00BN7SWP63
Diese Analysten bewerten die GSK-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| UBS AG | 19,40£ | 0,75% | 15.06.26 | |||
| Deutsche Bank AG | 19,00£ | -1,32% | 10.06.26 | |||
| JP Morgan Chase & Co. | 17,00£ | -11,71% | 09.06.26 | |||
| Barclays Capital | 18,00£ | -6,52% | 09.06.26 | |||
| Jefferies & Company Inc. | 25,00£ | 29,84% | 03.06.26 | |||
| Bernstein Research | 26,30£ | 36,59% | 05.05.26 | |||
| Goldman Sachs Group Inc. | 18,70£ | -2,88% | 30.04.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 20,00£ | 3,87% | 17.02.26 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|